GEISINGER MEDICAL CENTER
Health Inspection Results For:
There are 609 surveys for this facility. Please select a date to view the survey results.
Surveys don't appear on this website until at least 41 days have elapsed since the exit date of the survey.
This report is the result of an off-site occupancy survey conducted on March 4, 2019, at Geisinger Medical Center which included new service: Lutetium- 177 Peptide Receptor Radionuclide Therapy. Based on the provided documents, it was determined the facility was in compliance with all applicable requirements of the Pennsylvania Department of Health's Rules and Regulations for Hospitals, 28 Pa Code, Part IV, Subparts A and B, November 1987, as amended June 1998 and the current edition of the Guidelines for Design and Construction of Hospital and Health Care Facilities.
Plan of Correction: